A Potent SARS-CoV-2 Neutralising Nanobody Shows Therapeutic Efficacy in the Syrian Golden Hamster Model of COVID-19

Researchers report four nanobodies engineered as homotrimers with pmolar affinity for the receptor binding domain of the SARS-CoV-2 spike protein.